GeneReach Biotechnology Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	232.74	206.49	225.46	750.02	1,012
Revenue Growth (YoY)	12.71%	-8.42%	-69.94%	-25.89%	18.09%
Cost of Revenue	71.82	88.21	197.88	259.95	265.1
Gross Profit	160.93	118.28	27.58	490.07	746.98
Selling, General & Admin	175.09	173.63	173.98	191.05	202.96
Research & Development	72.75	80.51	61.46	58.81	56.61
Operating Expenses	240.79	249.49	256.87	248.73	264.63
Operating Income	-79.86	-131.22	-229.29	241.34	482.35
Interest Expense	-6.51	-5.93	-5.76	-6.61	-6.26
Interest & Investment Income	9.03	18	14.47	2.29	0.39
Currency Exchange Gain (Loss)	-21.52	28.89	0.45	29.39	-11.55
Other Non Operating Income (Expenses)	-4.33	1.45	3.57	2.98	3.32
EBT Excluding Unusual Items	-103.19	-88.81	-216.55	269.38	468.24
Gain (Loss) on Sale of Investments	-	-	-	-	0.04
Gain (Loss) on Sale of Assets	-0.5	-0.57	-1.39	1.7	0.41
Asset Writedown	-13	-27.6	-	-	-
Other Unusual Items	0.22	-	-0.41	1.29	0.68
Pretax Income	-116.47	-116.98	-218.35	272.37	469.37
Income Tax Expense	-3.54	6.7	-47.99	54.88	98.9
Earnings From Continuing Operations	-112.93	-123.68	-170.35	217.49	370.47
Minority Interest in Earnings	2.65	4.95	4.08	3.85	6.15
Net Income	-110.28	-118.73	-166.27	221.34	376.62
Net Income to Common	-110.28	-118.73	-166.27	221.34	376.62
Net Income Growth	-	-	-	-41.23%	46.38%
Shares Outstanding (Basic)	57	57	57	57	57
Shares Outstanding (Diluted)	57	57	57	59	59
Shares Change (YoY)	-0.79%	-	-3.08%	1.13%	1.88%
EPS (Basic)	-1.93	-2.07	-2.89	3.85	6.55
EPS (Diluted)	-1.93	-2.07	-2.89	3.77	6.45
EPS Growth	-	-	-	-41.59%	44.19%
Free Cash Flow	-19.87	-30.35	-62.21	307.76	329.43
Free Cash Flow Per Share	-0.35	-0.53	-1.08	5.19	5.62
Dividend Per Share	-	-	-	1.200	3.636
Dividend Growth	-	-	-	-67.00%	45.43%
Gross Margin	69.14%	57.28%	12.23%	65.34%	73.81%
Operating Margin	-34.31%	-63.55%	-101.70%	32.18%	47.66%
Profit Margin	-47.38%	-57.50%	-73.75%	29.51%	37.21%
Free Cash Flow Margin	-8.54%	-14.70%	-27.59%	41.03%	32.55%
EBITDA	-22.24	-69.95	-174.3	292.82	531.28
EBITDA Margin	-9.55%	-33.88%	-77.31%	39.04%	52.49%
D&A For EBITDA	57.62	61.26	54.98	51.47	48.93
EBIT	-79.86	-131.22	-229.29	241.34	482.35
EBIT Margin	-34.31%	-63.55%	-101.70%	32.18%	47.66%
Effective Tax Rate	-	-	-	20.15%	21.07%
Revenue as Reported	-	-	225.46	750.02	1,012

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.